Literature DB >> 7173571

Clinical usefulness of serum cholylglycine determination in various liver diseases.

Y Tanggo, S Fujiyama, F Kin, A Tashiro, H Shiraoku, M Akahoshi, Y Sato, O Hashiguchi, K Sagara.   

Abstract

In order to study the clinical significance of cholylglycine (CG), CG in both fasting levels and after oral loading of 300 mg ursodeoxycholic acid (UDCA) were determined by radioimmunoassay in 313 patients with various liver diseases. Elevated fasting CG levels were found in 66.6% of patients with acute hepatitis (AH), 34.8% chronic inactive hepatitis (CIH), 79.3% chronic active hepatitis (CAH), 97.1% liver cirrhosis (LC), 94.7% hepatocellular carcinoma (HCC), and 80% of gall stones (GS). Changes of fasting CG during the course of AH were found to be parallel with values of transaminases. On oral loading of UDCA, different CG responses were found in CIH and CAH, and in compensated and decompensated LC. From these results we concluded that the determinations of serum CG gave additional informations of various liver diseases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173571     DOI: 10.1007/bf02774722

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  11 in total

1.  A simple and sensitive assay of total serum bile acids.

Authors:  F Mashige; K Imai; T Osuga
Journal:  Clin Chim Acta       Date:  1976-07-01       Impact factor: 3.786

2.  Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.

Authors:  M G Korman; A F Hofmann; W H Summerskill
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

3.  [A comparative study of serum bile acid levels (TBA, CG) in liver disease-difference between fasting and UDCA oral loading (author's transl)].

Authors:  K Hino; S Yamamoto; S Yamashita; K Fukushima; K Ohashi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1981-11

4.  [Clinical significance of serum bile acid radioimmunoassay in hepatobiliary diseases--with special reference to the CG/SLCG ratio (author's transl)].

Authors:  Y Oshiumi; S Koga; I Kamoi; H Nishitani; Y Ichiya; H Ibayashi; K Matsuura
Journal:  Radioisotopes       Date:  1979-10-15

5.  Clinical significance of serum bile acid measurement in liver diseases.

Authors:  T Morita; Y Matsuyama; T Fujimoto; M Higuchi; T Tsujii; Y Matsuoka
Journal:  Gastroenterol Jpn       Date:  1978

6.  Levels of immunoreactive glycine-conjugated bile acids in health and hepatobiliary disease.

Authors:  L M Demers; G W Hepner
Journal:  Am J Clin Pathol       Date:  1976-11       Impact factor: 2.493

7.  Clinical value of serum bile acid levels in chronic hepatitis.

Authors:  M B Jones; S Weinstock; R L Koretz; K J Lewin; J Higgins; G L Gitnick
Journal:  Dig Dis Sci       Date:  1981-11       Impact factor: 3.199

8.  Evaluation of fasting serum bile acid concentration in patients with liver and gastrointestinal disorders.

Authors:  K Samuelson; A Aly; C Johansson; A Norman
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

9.  Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption.

Authors:  N F LaRusso; M G Korman; N E Hoffman; A F Hofmann
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

10.  Serum bile acids in acute hepatitis.

Authors:  P Tobiasson; A Forkman
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

View more
  2 in total

1.  Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.

Authors:  Andrew D Patterson; Olivier Maurhofer; Diren Beyoglu; Christian Lanz; Kristopher W Krausz; Thomas Pabst; Frank J Gonzalez; Jean-François Dufour; Jeffrey R Idle
Journal:  Cancer Res       Date:  2011-09-07       Impact factor: 12.701

2.  Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.

Authors:  Jeremiah Bowers; Emma Hughes; Nicholas Skill; Mary Maluccio; Daniel Raftery
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-03-02       Impact factor: 3.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.